03/29/2024
During cell-specific treatments such as , hematopoietic stem and progenitor cells (HSPCs) can undergo significant harm leading to a reduction in the , a condition often associated with . Learn more here: https://bit.ly/3tIU5r9.
G1 Therapeutics, Inc. Community guidelines: https://www.g1therapeutics.com/social-guidelines
Research Triangle Park, NC
27709
Be the first to know and let us send you an email when G1 Therapeutics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to G1 Therapeutics, Inc.: